Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE BAIE SIDE : revenue, balance sheet and financial ratios

SELARL PHARMACIE BAIE SIDE is a French company founded 20 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PETIT-BOURG (97170), this company of category PME shows in 2024 a net income positive of 270 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE BAIE SIDE (SIREN 482609187)
Indicator 2024 2023 2022 2021 2020
Revenue N/C N/C N/C N/C N/C
Net income 270 413 € 118 742 € 298 553 € 118 312 € 482 326 €
EBITDA N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SELARL PHARMACIE BAIE SIDE generates positive net income of 270 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2024: 482 k€ -> 270 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

270 413 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 78%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.866%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

78.476%

Solvency indicators evolution
SELARL PHARMACIE BAIE SIDE

Sector positioning

Debt ratio
0.87 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent

In 2024, the debt ratio of SELARL PHARMACIE BAIE SIDE (0.87) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
78.48% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent +6 pts over 3 years

In 2024, the financial autonomy of SELARL PHARMACIE BAIE SIDE (78.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Positioning of SELARL PHARMACIE BAIE SIDE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE BAIE SIDE is estimated at 3 775 165 € (range 2 628 965€ - 5 647 863€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
2628k€ 3775k€ 5647k€
3 775 165 € Range: 2 628 965€ - 5 647 863€
NAF 5 année 2024

Valuation method used

Net Income Multiple
270 413 € × 14.0x = 3 775 165 €
Range: 2 628 965€ - 5 647 863€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE BAIE SIDE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE BAIE SIDE

What is the revenue of SELARL PHARMACIE BAIE SIDE ?

The revenue of SELARL PHARMACIE BAIE SIDE is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE BAIE SIDE profitable?

Yes, SELARL PHARMACIE BAIE SIDE generated a net profit of 270 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE BAIE SIDE ?

The headquarters of SELARL PHARMACIE BAIE SIDE is located in PETIT-BOURG (97170), in the department Guadeloupe.

Where to find the tax return of SELARL PHARMACIE BAIE SIDE ?

The tax return of SELARL PHARMACIE BAIE SIDE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE BAIE SIDE operate?

SELARL PHARMACIE BAIE SIDE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.